Legence Corp. (LGN) posts 2025 growth, record $3.7B backlog and raises 2026 guidance
Rhea-AI Filing Summary
Legence Corp. reported strong growth for the fourth quarter and full year 2025, while remaining unprofitable. Q4 revenue reached $737.6 million, up 34.6% from a year earlier, with non-GAAP Adjusted EBITDA rising 53.2% to $87.0 million. Full-year 2025 revenue was $2.6 billion, up 21.5%, and non-GAAP Adjusted EBITDA increased 30.1% to $298.8 million. Despite this, Legence recorded a Q4 net loss attributable to the company of $32.7 million and a full-year net loss of $59.8 million. Backlog and awarded contracts climbed to a record $3.7 billion, a 48.6% increase, with a Q4 book-to-bill of 1.9x. The Installation & Maintenance segment led growth, while Engineering & Consulting grew more modestly with slightly lower margins.
Legence completed acquisitions of Metrix Engineers and, earlier in 2026, The Bowers Group, using cash and additional debt and equity. At December 31, 2025, the company held $230.2 million of cash and $825.1 million of total debt, corresponding to net leverage of 2.0x based on trailing 12‑month non-GAAP Adjusted EBITDA. Management issued first-quarter 2026 guidance for revenue of $925–$950 million and non-GAAP Adjusted EBITDA of $90–$100 million, and raised full-year 2026 guidance to revenue of $3.7–$3.9 billion and non-GAAP Adjusted EBITDA of $400–$430 million, reflecting expected contributions from recent acquisitions and strong demand in data centers, state and local government, and life sciences markets.
Positive
- Strong revenue and EBITDA growth: Q4 2025 revenue rose 34.6% to $737.6 million, and non-GAAP Adjusted EBITDA increased 53.2% to $87.0 million; full-year revenue grew 21.5% to $2.6 billion with Adjusted EBITDA up 30.1% to $298.8 million.
- Record backlog and healthy book-to-bill: Backlog and awarded contracts reached a record $3.7 billion, up 48.6% year over year, with a Q4 book-to-bill ratio of 1.9x and full-year ratio of 1.6x, supporting forward revenue visibility.
- Improving non-GAAP profitability metrics: Consolidated non-GAAP Adjusted Gross Profit and Adjusted Gross Margin improved to $549.7 million and 21.6% in 2025, up from $432.1 million and 20.6%, reflecting better underlying project economics.
- Raised 2026 guidance: Management set 2026 revenue guidance at $3.7–$3.9 billion and non-GAAP Adjusted EBITDA at $400–$430 million, higher than prior targets and incorporating expected contributions from acquisitions.
- Balanced leverage profile: With cash and equivalents of $230.2 million and total debt of $825.1 million at December 31, 2025, net leverage stood at 2.0x trailing 12‑month non-GAAP Adjusted EBITDA, indicating moderate leverage given growth.
Negative
- Continued net losses: Despite strong growth, Legence recorded a Q4 2025 net loss attributable to the company of $32.7 million and a full-year net loss of $59.8 million, both wider than in 2024.
- Margin pressure in key segment: Engineering & Consulting gross margin declined, with non-GAAP Adjusted Gross Margin for 2025 at 34.0% versus 34.2% in 2024, and Q4 non-GAAP Adjusted Gross Margin at 30.9%, reflecting mix shifts and lower margins in certain end markets.
- Significant non-operating and non-cash charges: Results include goodwill impairment of $24.97 million, long-lived asset impairment of $2.42 million, and elevated stock-based compensation of $68.0 million in 2025, all contributing to GAAP net losses.
- Higher interest and financing costs: Total interest expense of $101.8 million, debt extinguishment losses of $6.7 million and credit agreement fees of $6.3 million in 2025 weigh on earnings and reflect a meaningful debt burden.
- Acquisition execution and integration risk: The Metrix and Bowers transactions add scale and backlog, but also increase operational complexity and leverage; achieving the anticipated growth and margin benefits depends on successful integration.
Insights
Legence posts rapid growth and record backlog but remains loss-making while raising 2026 guidance.
Legence Corp. delivered robust top-line expansion in 2025, with revenue up 21.5% to $2.6 billion and non-GAAP Adjusted EBITDA up 30.1% to $298.8 million. Growth is broad-based, particularly in Installation & Maintenance and data center, life science and public-sector end markets.
However, the company still reported a full-year net loss attributable to Legence of $59.8 million, pressured by higher selling, general and administrative expenses, goodwill and asset impairments, interest costs and significant stock-based compensation. Net loss widened versus 2024 even as margins improved on a non-GAAP basis.
Backlog and awarded contracts reached a record $3.7 billion, up 48.6%, with book-to-bill of 1.6x for 2025, supporting future revenue visibility. Acquisitions of Metrix and Bowers increase scale but also add leverage, with year-end cash of $230.2 million and debt of $825.1 million. Management’s higher 2026 revenue and Adjusted EBITDA guidance signals confidence in sustained demand and integration of recent deals.
FAQ
How did Legence Corp. (LGN) perform financially in Q4 2025?
What were Legence Corp.’s full-year 2025 results?
How large is Legence Corp.’s backlog and book-to-bill ratio?
What guidance did Legence Corp. provide for 2026?
What acquisitions did Legence Corp. complete around year-end 2025?
What is Legence Corp.’s balance sheet position and leverage?
How did Legence’s segments perform in 2025?
Filing Exhibits & Attachments
4 documents